We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current AGIO market cap is 2.48B. The company's latest EPS is USD -6.2655 and P/E is -7.03.
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 5.61M | 6.71M | 7.4M | 7.1M | 8.19M |
| Operating Income | -90.61M | -93.7M | -100.9M | -106.28M | -92.07M |
| Net Income | -81.02M | -83.81M | -91.32M | -95.94M | -81.55M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 117.91M | 203.2M | 0 | 14.24M | 26.82M |
| Operating Income | -426.33M | -316.15M | -378.42M | -389.05M | -391.49M |
| Net Income | -411.47M | -327.37M | 1.6B | -231.8M | -352.09M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 1.15B | 1.09B | 1.01B | 937.12M | 849.71M |
| Total Liabilities | 114.77M | 120.92M | 120.42M | 126.1M | 105.79M |
| Total Equity | 1.04B | 964.24M | 886.84M | 811.02M | 743.92M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 890.74M | 852.95M | 1.44B | 1.24B | 937.12M |
| Total Liabilities | 250.21M | 453.45M | 145.76M | 137.9M | 126.1M |
| Total Equity | 640.53M | 399.5M | 1.29B | 1.1B | 811.02M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -95.18M | -161.93M | -223.57M | -296.06M | -99.87M |
| Investing | 57.6M | 104.72M | 144.06M | 239.58M | 124.56M |
| Financing | 2.47M | 2.7M | 4.59M | 5.43M | 5.86M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -370.62M | -290.76M | -407.32M | -309.48M | -296.06M |
| Investing | 91.44M | 75.75M | 1.25B | 243.26M | 239.58M |
| Financing | 289.61M | 261.52M | -765.77M | 2.35M | 5.43M |
| Market Cap | 2.48B |
| Price to Earnings Ratio | -7.03 |
| Price to Sales Ratio | 92.29 |
| Price to Cash Ratio | 28.06 |
| Price to Book Ratio | 3.05 |
| Dividend Yield | - |
| Shares Outstanding | 56.19M |
| Average Volume (1 week) | 726.61k |
| Average Volume (1 Month) | 1.03M |
| 52 Week Change | 66.08% |
| 52 Week High | 49.055 |
| 52 Week Low | 19.795 |
| Spread (Intraday) | 0.63 (1.42%) |
| Company Name | Agios Pharmaceuticals Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.agios.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
